NeuroMetrixNURO
Market Cap: $7.74M
About: NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
Employees: 26
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
57% more capital invested
Capital invested by funds: $131K [Q1] → $205K (+$74.4K) [Q2]
1.22% more ownership
Funds ownership: 1.54% [Q1] → 2.76% (+1.22%) [Q2]
8% less funds holding
Funds holding: 12 [Q1] → 11 (-1) [Q2]
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Research analyst outlook
We haven’t received any recent analyst ratings for NURO.